AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Acerca de

Xylem Inc. (NYSE: XYL) es una empresa líder global de tecnología del agua dedicada a resolver desafíos críticos de agua e infraestructura a través de su cartera de medición inteligente, bombas, sistemas de tratamiento y plataformas de análisis utilizadas por servicios públicos, instalaciones industriales y edificios comerciales en todo el mundo. La adquisición de Xylem en 2023 de Evoqua Water Technologies expandió significativamente sus capacidades de tratamiento de agua y soluciones industriales de agua, creando una plataforma integral de tecnología del agua que abarca el ciclo completo del agua desde la recolección y distribución hasta el uso, tratamiento y devolución. El enfoque de Xylem en soluciones inteligentes de agua, infraestructura inteligente y la creciente necesidad de abordar sistemas de agua envejecidos y escasez de agua la posiciona como una inversión de tecnología del agua de alto crecimiento con fuertes vientos de cola seculares.

Acciones de adaptación climática

Xylem es un líder global en tecnología del agua dedicado a resolver desafíos críticos de infraestructura hídrica, con productos para tratamiento, transporte y análisis de agua esenciales para la adaptación al cambio climático.

Acciones de Agua

Xylem es una empresa líder en tecnología del agua que proporciona soluciones inteligentes de infraestructura incluyendo bombas, sistemas de tratamiento, análisis y plataformas de monitoreo digital que ayudan a empresas de servicios públicos e industrias a gestionar el agua de manera más eficiente en todo el ciclo del agua.

Key Financials XYL

Precio $128.09
Cambio (1D) +1.58%
Cambio (30D) -5.94%
Cambio (60D) -9.15%
Cambio (90D) -14.55%
Cambio (180D) +1.94%
Cambio (1Y) -1.40%
Cambio (5Y) +26.58%
P/E Ratio 25.47
EPS (TTM) $5.03
Rango de 52 semanas $100.47 — $154.27
MA de 50 días $138.47
Volumen 2.42M

Data updated Feb 15 · Source: Twelve Data

4.6
2 reviews
Claude Opus 4.6
AI Review
4.6/5

Xylem is a premier pure-play water technology company, offering solutions across water transport, treatment, testing, and smart infrastructure. The 2023 acquisition of Evoqua Water Technologies significantly expanded its treatment capabilities and created meaningful cross-selling opportunities. With a P/E of 25.47 and EPS of $5.03, the stock trades at a premium but one arguably justified by its dominant market position in a secular growth industry. Global water scarcity, aging infrastructure, and tightening regulations provide powerful long-term tailwinds. The recent pullback of ~14.5% over 90 days brings the price closer to fair value territory, currently sitting well below its 50-day moving average of $138.47. Bull case: irreplaceable positioning in essential water infrastructure with recurring revenue streams and margin expansion from Evoqua synergies. Bear case: integration risks, cyclical exposure to municipal spending, and elevated valuation relative to industrial peers. The balance sheet carries acquisition-related debt that warrants monitoring. For investors seeking exposure to water megatrends and climate resilience, Xylem remains a cornerstone holding with strong competitive moats.

Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.6/5

Xylem Inc. (XYL) stands as a premier pure-play in the water technology sector, offering essential solutions for water transport, treatment, and testing. The company benefits from strong secular tailwinds, including global water scarcity and the urgent need to upgrade aging utility infrastructure. The recent integration of Evoqua Water Technologies has further solidified its competitive moat by expanding its service capabilities. Currently trading at $128.92 with a P/E ratio of 26.64, valuation remains elevated compared to broader industrials but reflects the premium assigned to its market leadership and ESG credentials. The stock has recently pulled back significantly from its 52-week high of $154.27 and is trading below its 50-day moving average, potentially offering a tactical entry point for long-term investors. While cyclical risks in industrial spending persist, Xylem's diverse portfolio provides resilience.

Feb 11, 2026
Xylem Inc Screenshot

Added: Feb 10, 2026

xylem.com

Latest from Otrai

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

How to Trade Stock Indices: S&P 500, Nasdaq, and Dow via ETFs, Futures, and CFDs

A stock index is a single number that summarizes the price action of a basket of companies. The S&P 500 tracks roughly 500 large US firms, the Nasdaq-100 tracks the 100 largest non-financial names on the Nasdaq exchange, and the Dow Jones Industrial Average follows 30 blue-chip stocks.

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Options Greeks Explained: Delta, Gamma, Theta, and Vega

The Greeks explain why an option costs what it costs and how that price changes when the stock moves, time passes, and volatility shifts. Delta, Gamma, Theta, and Vega, made accessible.

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart Patterns That Actually Work: Head & Shoulders, Triangles, Flags & Double Tops

Chart patterns are the most recognizable part of technical analysis and the most misunderstood. Most fail or break out the wrong way before reversing. This guide covers head and shoulders, double tops and bottoms, triangles, and flags — with realistic reliability, target measurement, and false-breakout confirmation.

Cómo hacer backtest de una estrategia de trading: métodos, errores y qué significan realmente los resultados

Cómo hacer backtest de una estrategia de trading: métodos, errores y qué significan realmente los resultados

Cada trader tiene una estrategia que se ve genial en su cabeza. El backtesting es cómo descubres si realmente funciona. Aquí hay cómo probar estrategias correctamente, qué métricas importan y por qué la mayoría de los resultados de backtest son demasiado buenos para ser verdad.